Marmesinine -C20H24O9, coumarin β -D-glucoside derivative -appears in several plants -e.g. Ruta graveolens, playing role of biocontrolling, antipathogenic compound. Marmesinine was first isolated by Reisch in 1970. Its molecular structure was assigned using NMR spectroscopy by Duddeck and coworkers (1993). In spite of development in separation techniquesmarmesinine is difficult to crystallize, appearing as 'amorphous powder' (Kitayama, 2001). The crystal structure of marmesinine was determined from single microcrystal diffraction and, independently, from powder diffractionwith the aim of comparing the conformations and precision of both structural models.
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The single crystal experiment ( CAD-4 diffractometer, copper radiation), yielded lattice parameters a = 7.8503, b = 5.9850, c = 40.579 Å,
, in P212121 space group. The structure was solved and refined to R = 0.035, and could serve as good reference for powder methods. The powder diffraction experiments (Grochowski, Serda, Baehtz, Knapp, 2001) , were done on the B2 beamline of DESY-HASYLAB (Hamburg) using wavelength 1.3572 Å and a channel-cut type analyzer crystal. The pattern was indexed with TREOR90 giving lattice parameters a = 7.8449(3), b = 5.9903(2), c = 40.598(2) Å,
with figure of merit M20=158, F20=506. The effective resolution of the data (d = 1.75 Å) was limited by the sample, hence structure solution was attempted by global optimization rather than direct methods. Structure solution was carried out by simulated annealing, using the program DASH ver. 2.0. Several simulated annealing runs were tried to achieve the global minimum. The work was carried out under DESY-HASYLAB I-00-024 Project, and supported by ARI-EC Contract. Quinolones are common antibacterial agents consisting N1-substituted 4-oxo-1,4-dihydroquinoline with an acidic function at C3. Two main models of their actions have been proposed in the literature. One model is based on quinolones interactions with gyrase-DNA complex (through hydrogen bonds with guanine) and the other on intercalation. Also binding with phosphate oxygens of DNA via magnesium bridge has been considered. As a detailed molecular mechanism of antibacterial quinolones action as well as crystal structure of gyrase are not known, information from crystal structures of quinolones and their analogs is very valuable. The most important observations are: (1) Quinolones occur in the crystal state predominantly in a neutral form with intramolecular hydrogen bond 'locking' acidic H atom of carboxylic group. It assures good permeability of quinolones through cell membranes. (2) Quinolones show strong preference for stacking in dimers of antiparallel orientations. The observation leads to modification of existing (Shen) model of quinolone -DNA interactions and suggest that the most probable place of quinolone binding is GC/CG region. Therefore we have designed new analogs of quinolones interacting through hydrogen bonds with cytosine. The compounds showed antibacterial activity similar to that of nalidixic acid. (3) We have shown that substituents making partial negative charges at carbonyl oxygens larger have higher activity. It supports a model of quinolones interactions with DNA through hydrogen bonds with guanine. We aim to determine the crystal structure of several non-nucleoside inhibitors of HIV-1 reverse transcriptase (RT). We found that derivatives of 2,6-difluorobenzyl benzimidazole inhibit HIV-1 RT and could be looked at as members of non-nucleoside inhibitors (NNRTI). These inhibitors are also known as butterfly inhibitors because their common characteristic is the presence of two π -electron moieties with a slant orientation. One of the crucial geometrical parameters is the dihedral angle between the planes of the π -electron systems. There is a specific optimal value for this parameter and only the compounds, which meet it, are potentially active. The active conformation determines the optimal torsion angles within the 2,6-difluorobenzyl and the 2,6-difluorphenyl. We found that different substituents at the C4 position of the benzimidazole moiety had dramatically varied anti-viral activity. The crucial parameters for activity are the size of the substituent, polar and hydrophobic distribution of the spatial regions, and orientation of the substituents in respect to the benzymidazol ring. Structural data is very useful to determine the correlation between the threedimensional structure of inhibitor and its biological activity. It is also a good base for modeling enzyme-inhibitor interaction and designing new much more active compounds.
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